PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales: Zamani, Shayan, Azhdari, Hamed, Mehdizadeh, Mahshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429527/
http://dx.doi.org/10.1097/01.HS9.0000976452.92369.02
_version_ 1785090737176576000
author Zamani, Shayan
Azhdari, Hamed
Mehdizadeh, Mahshid
author_facet Zamani, Shayan
Azhdari, Hamed
Mehdizadeh, Mahshid
author_sort Zamani, Shayan
collection PubMed
description
format Online
Article
Text
id pubmed-10429527
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295272023-08-17 PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION Zamani, Shayan Azhdari, Hamed Mehdizadeh, Mahshid Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429527/ http://dx.doi.org/10.1097/01.HS9.0000976452.92369.02 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Zamani, Shayan
Azhdari, Hamed
Mehdizadeh, Mahshid
PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title_full PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title_fullStr PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title_full_unstemmed PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title_short PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
title_sort pb2436: efficacy and safety profile of everolimus as a maintenance therapy for primary refractory/relapsing hodgkin lymphoma following autologous hematopoietic stem cell transplantation
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429527/
http://dx.doi.org/10.1097/01.HS9.0000976452.92369.02
work_keys_str_mv AT zamanishayan pb2436efficacyandsafetyprofileofeverolimusasamaintenancetherapyforprimaryrefractoryrelapsinghodgkinlymphomafollowingautologoushematopoieticstemcelltransplantation
AT azhdarihamed pb2436efficacyandsafetyprofileofeverolimusasamaintenancetherapyforprimaryrefractoryrelapsinghodgkinlymphomafollowingautologoushematopoieticstemcelltransplantation
AT mehdizadehmahshid pb2436efficacyandsafetyprofileofeverolimusasamaintenancetherapyforprimaryrefractoryrelapsinghodgkinlymphomafollowingautologoushematopoieticstemcelltransplantation

Ejemplares similares